Table 2.
Yeast probiotic/components | Model of study | Anti-cancer effects | Ref |
---|---|---|---|
Heat-killed S. cerevisiae | Breast cancer cells (MCF-7 and ZR-75-1) and non-metastatic breast cancer cells (HCC70) |
Induction of apoptosis Mitochondrial membrane Disruption Activation of caspases (8, 9 and 3) |
[70] |
Squamous cell carcinomas of the tongue (SCC-4 and SCC-9) and adenocarcinomas of the colon (Caco-2 and DLD-1) | Induction of apoptosis | [71] | |
SW480 | Lower the of expression of p-Akt1, Rel A, Bcl-XL, pro-caspase 3, and pro-9, and could rise the BAX, cleaved caspase-3, and cleaved caspase-9 expression | [72] | |
HeLa | Induction of apoptosis: cell enlargement, membrane bleb, and chromatin condensation | [73] | |
Mice model of Solid Ehrlich Carcinoma tumor (SEC) |
Cause tumor degeneration, apoptosis, and ischemic (coagulative) and liquefactive necrosis Recruitment the leukocytes, macrophages into the tumors Higher the TNF-α and IFN-gamma plasma and lowered the IL-10 levels |
[74] | |
Metastatic breast cancer (MBC) cells | Cells phagocytized yeast and underwent apoptosis due to elevation of intracellular Ca2+, decreasedBcl-2 expression and increase in Bax expression | [75] | |
Supernatant of S. cerevisiae | HT-29 colon cancer cell line |
Higher the PTEN and Caspas3 expression Lower the Bclxl and RelA genes expression Induce apoptosis and reduce the metastasis |
[76] |
Ergosterol | MCF-7 cells | Produce the oxidation form of ergosterol and inhibit the cancer cells growing | [77] |
β-glucan of S. cerevisiae | CHO-k1 and CHO-xrs5 cell lines | Prevent DNA damage | [78] |
Patients with advanced breast cancer | Induced the proliferation and activation of peripheral blood monocytes | [79] | |
Lung metastasis of colon 26-M3.1 carcinoma or B16-BL6 melanoma cells | Macrophages were induced by IS-2 and produced cytokines (IL-1β, IFN-γ, and IL-12). | [80] | |
Mice feeding with the insoluble β-glucan (1 week), murine hepatoma MH-22a cells | Increase the count of neutrophil blood and reduce the lymphocyte count | [81] | |
S180 tumor-bearing mice |
Decrease the weight and tumor volume Decrease the CD4–CD8 ratio Increase the IL-2, IL-6, and TNF-α levels Up-regulate the Bax expression Down-regulate the Bcl-2 expression |
[82] | |
Saccharomyces boulardii | ApcMin mice orally received the yeast | Inhibits EGFR and other receptor tyrosine kinase signaling | [83] |
Carboxymethyl-glucan: soluble derivative of β-glucan | Advanced prostate cancer patients |
Higher the total leukocyte count, red blood cell, hematocrit, hemoglobin and platelet counts. Could be an adjuvant to cancer treatment |
[84] |
Cytoplasmic extract and cell wall of S. cerevisiae and S. boulardi | Cell line K562 | Cell apoptosis and necrosis | [85] |
Selenium-enriched S. cerevisiae | Rats model of CRC | Reduce CRC progression by decrease the number / size of aberrant crypt foci (ACF) and alteration the function of P53, BCL2, and CD31 | [86] |
Mucositis mice induced by 5FU | Selenium-enriched yeast reduced eosinophil peroxidase activity | [87] | |
S. boulardii: Insoluble glucan, cell wall polysaccharides | Male F344 rat CRC model |
↓ACF: prevention biomarkers Reduction of quinone reductase activity |
[60] |
HT-29 cell lines | antiradical and anti-proliferative effect | [60] | |
Herbal medicine and S. cerevisiae | Hepatocellular carcinoma HepG2 cells HepG2 cells- bearing nude mice model |
Anti-proliferation effect Inhibit tumor growth |
[88] |
Paclitaxel in the presence or absence of S. cerevisiae |
Metastatic murine 4 T1 line Murine Ehrlich ascites carcinoma (EAC) line Human breast cancer MCF-7 line |
Decreased 4 T1 cell viability, triggered DNA damage, induced the apoptosis, and inhibit cell proliferation Chemosensitizing effect of yeast along with paclitaxel increased Be as novel adjuvant for chemotherapy treatment |
[89] |